News

The Centers for Medicare & Medicaid Services (CMS) is piloting a new Medicare Choices Care Model, designed to provide a new option for Medicare beneficiaries to concurrently receive palliative care services from hospice providers while also receiving services from curative care providers.

Benefits seen when intake is 7 or more servings per day.

The American Society of Clinical Oncology (ASCO) announced today three new evidence-based clinical practice guidelines on neuropathy, fatigue, and depression and anxiety in cancer survivors, the first three in a planned series of ASCO guidelines on survivorship care.

Patients who had a high Body Mass Index (BMI) before being diagnosed with colorectal cancer had an increased risk of death after diagnosis, even if their tumor harbored the microsatellite instability (MSI) marker

Women with irregular menstrual cycles have a 2.4-fold increased risk of death from ovarian cancer, according to a large, prospective study presented at the 2014 AACR Annual Meeting.

Continued monitoring of long-term effects of these drugs is warranted.

Palbociclib, an inhibitor of cyclin-dependent kinases (CDK) 4 and 6, more than doubled progression-free survival (PFS) when used in combination with letrozole for patients with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer

Women who took the fertility drugs clomiphene citrate (Clomid) or gonadotropins did not experience an increased risk for breast cancer compared with women who were not treated with those medications, according to a 30-year follow-up study published in the April issue of Cancer Epidemiology, Biomarkers & Prevention.

Study from one cancer center shows low knowledge and comfort levels.

Early-stage overweight endometrial and breast cancer survivors had moderate success in lowering their body mass index (BMI) and waste circumference after using the web and smart phone/tablet–based weight loss application "Lose It!"

A new study has found that one in four breast cancer survivors report that they are worse off financially even 4 years after their last treatment and 12% report they still have medical debt from their treatment.

Very few (1.3%) clinical cancer studies focus on people of non-white races.

Last fall, I started working with a couple of nursing colleagues on a project which involves LinkedIn training for oncology nurses. The number one concern voiced ahead of the training by roughly a quarter of those nurses . . . and hundreds more in my personal conversations over the last year?

For Amy Berman, BS, RN, today's cancer care delivery system is a lot like the sound of 1 hand clapping: It can be out of sync and unproductive, because it fails to touch the patients it treats.

Incidence and mortality has decreased 30% over past 10 years.

Study suggests that more than half of all patients received second and third line therapies.

International researchers from seven countries conducted a prospective study to determine risk reduction of ovarian, fallopian tube, or peritoneal cancer in women with a BRCA1 or BRCA2 mutation after oophorectomy and examine other factors, such as impact of this procedure on mortality and five year survival.

Second largest drugstore chain phasing our tobacco products by 10/1/14

The FDA has granted an accelerated approval to ibrutinib (Imbruvica) as a treatment for patients with chronic lymphocytic leukemia

On February 3, 2014 the U.S. Department of Health and Human Services (HHS) enacted a rule that will give patients direct access to their laboratory results.

Pretty sure my mom would say questioning the status quo started at a very young age . . ."If I said the moon was white, you would say it was black...just to be different." I recall feeling frustrated when my kindergarten teacher did not want me to ‘color outside the lines.' Why not?

Eltrombopag (Promacta), a small molecule thrombopoietin receptor (TPOR) agonist, has received a Breakthrough Therapy designation from the FDA for the treatment of cytopenias in patients with severe aplastic anemia (SAA) who have had insufficient response to immunosuppressive therapy.

Searchable phone app provides information on herbs, complementary therapies, and more.

Social Security Administration now includes several more cancer diagnoses.

However, incidence still far surpasses the Healthy People 2020 goal.

Differences in lung cancer incidence between men and women narrow with decreasing age.

The FDA has approved the first-ever targeted therapy combination for patients with unresectable or metastatic melanoma who harbor a BRAF V600E or V600K mutation

Canadian researchers led by Salaheddin M. Mahmud, MD, PhD of the University of Manitoba conducted a study to assess the effectiveness of the quadrivalent human papillomavirus (QHPV) vaccine against cervical dysplasia.